What is SARS-CoV-2 and what are we doing about it? A perspective from an antiviral pharmacologist

The campus community is invited to join Professor Brian Gentry on Monday, Nov. 30, at 2:30 p.m. as he discusses coronaviruses, what makes SARS-CoV-2 special (and more dangerous) compared to the other coronaviruses, the two primary scientific reasons this virus caused a pandemic, current and experimental pharmacotherapies for the treatment of COVID-19, and the outlook for a SARS-CoV-2 vaccine.

Join Microsoft Teams Meeting

— Kaylyn Maher, College of Pharmacy & Health Sciences